|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Roncucci L and Mariani F: Prevention of
colorectal cancer: How many tools do we have in our basket? Eur J
Intern Med. 26:752–756. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Brody H: Colorectal cancer. Nature.
521(S1)2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Angelova M, Charoentong P, Hackl H,
Fischer ML, Snajder R, Krogsdam AM, Waldner MJ, Bindea G, Mlecnik
B, Galon J and Trajanoski Z: Characterization of the
immunophenotypes and antigenomes of colorectal cancers reveals
distinct tumor escape mechanisms and novel targets for
immunotherapy. Genome Biol. 16(64)2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Obuch JC and Ahnen DJ: Colorectal cancer:
Genetics is changing everything. Gastroenterol Clin North Am.
45:459–476. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wang JY, Hsieh JS, Chang MY, Huang TJ,
Chen FM, Cheng TL, Alexandersen K, Huang YS, Tzou WS and Lin SR:
Molecular detection of APC, K- ras, and p53 mutations in the serum
of colorectal cancer patients as circulating biomarkers. World J
Surg. 28:721–726. 2004.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wu C, Zhu X, Tao K, Liu W, Ruan T, Wan W,
Zhang C and Zhang W: MALAT1 promotes the colorectal cancer
malignancy by increasing DCP1A expression and miR203
downregulation. Mol Carcinog. 57:1421–1431. 2018.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Yu Y, Liu D, Liu Z, Li S, Ge Y, Sun W and
Liu B: The inhibitory effects of COL1A2 on colorectal cancer cell
proliferation, migration, and invasion. J Cancer. 9:2953–2962.
2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chen LL and Carmichael GG: Long noncoding
RNAs in mammalian cells: What, where, and why? Wiley Interdiscip
Rev RNA. 1:2–21. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Martens-Uzunova ES, Böttcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151.
2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Arase M, Horiguchi K, Ehata S, Morikawa M,
Tsutsumi S, Aburatani H, Miyazono K and Koinuma D: Transforming
growth factor-β-induced lncRNA-Smad7 inhibits apoptosis of mouse
breast cancer JygMC(A) cells. Cancer Sci. 105:974–982.
2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
An X, Sarmiento C, Tan T and Zhu H:
Regulation of multidrug resistance by microRNAs in anti-cancer
therapy. Acta Pharm Sin B. 7:38–51. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wu Z, Liu X, Liu L, Deng H, Zhang J, Xu Q,
Cen B and Ji A: Regulation of lncRNA expression. Cell Mol Biol
Lett. 19:561–575. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ghazal S, McKinnon B, Zhou J, Mueller M,
Men Y, Yang L, Mueller M, Flannery C, Huang Y and Taylor HS: H19
lncRNA alters stromal cell growth via IGF signaling in the
endometrium of women with endometriosis. EMBO Mol Med. 7:996–1003.
2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li
YJ, Yan B and Jiang Q: Pathogenic role of lncRNA-MALAT1 in
endothelial cell dysfunction in diabetes mellitus. Cell Death Dis.
5(e1506)2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rodríguez-Malavé NI, Fernando TR, Patel
PC, Contreras JR, Palanichamy JK, Tran TM, Anguiano J, Davoren MJ,
Alberti MO, Pioli KT, et al: BALR-6 regulates cell growth and cell
survival in B-lymphoblastic leukemia. Mol Cancer.
14(214)2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yang L, Lin C, Jin C, Yang JC, Tanasa B,
Li W, Merkurjev D, Ohgi KA, Meng D, Zhang J, et al:
lncRNA-dependent mechanisms of androgen-receptor-regulated gene
activation programs. Nature. 500:598–602. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang YH, Fu J, Zhang ZJ, Ge CC and Yi Y:
LncRNA-LINC00152 down-regulated by miR-376c-3p restricts viability
and promotes apoptosis of colorectal cancer cells. Am J Transl Res.
8:5286–5297. 2016.PubMed/NCBI
|
|
20
|
Li J, Li Z, Zheng W, Li X, Wang Z, Cui Y
and Jiang X: LncRNA-ATB: An indispensable cancer-related long
noncoding RNA. Cell Prolif. 50(e12381)2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wei L, Wu T, He P, Zhang JL and Wu W:
LncRNA ATB promotes the proliferation and metastasis of lung cancer
via activation of the p38 signaling pathway. Oncol Lett.
16:3907–3912. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yue B, Qiu S, Zhao S, Liu C, Zhang D, Yu
F, Peng Z and Yan D: LncRNA-ATB mediated E-cadherin repression
promotes the progression of colon cancer and predicts poor
prognosis. J Gastroenterol Hepatol. 31:595–603. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gao Z, Zhou H, Wang Y, Chen J and Ou Y:
Regulatory effects of lncRNA ATB targeting miR-200c on
proliferation and apoptosis of colorectal cancer cells. J Cell
Biochem. 121:332–343. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yang X, Tao H, Wang C, Chen W, Hua F and
Qian H: lncRNA-ATB promotes stemness maintenance in colorectal
cancer by regulating transcriptional activity of the β-catenin
pathway. Exp Ther Med. 19:3097–3103. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Iguchi T, Uchi R, Nambara S, Saito T,
Komatsu H, Hirata H, Ueda M, Sakimura S, Takano Y, Kurashige J, et
al: A long noncoding RNA, lncRNA-ATB, is involved in the
progression and prognosis of colorectal cancer. Anticancer Res.
35:1385–1388. 2015.PubMed/NCBI
|
|
26
|
Zhang Y, Li J, Jia S, Wang Y, Kang Y and
Zhang W: Down-regulation of lncRNA-ATB inhibits
epithelial-mesenchymal transition of breast cancer cells by
increasing miR-141-3p expression. Biochem Cell Biol. 97:193–200.
2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ma CC, Xiong Z, Zhu GN, Wang C, Zong G,
Wang HL, Bian EB and Zhao B: Long non-coding RNA ATB promotes
glioma malignancy by negatively regulating miR-200a. J Exp Clin
Cancer Res. 35(90)2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li S, Hao J, Hong Y, Mai J and Huang W:
Long non-coding RNA NEAT1 promotes the proliferation, migration,
and metastasis of human breast-cancer cells by inhibiting
miR-146b-5p expression. Cancer Manag Res. 12:6091–6101.
2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42 (Database Issue):D92–D97. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yang JH, Li JH, Shao P, Zhou H, Chen YQ
and Qu LH: starBase: A database for exploring microRNA-mRNA
interaction maps from Argonaute CLIP-Seq and Degradome-Seq data.
Nucleic Acids Res. 39 (Database Issue):D202–D209. 2011.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Huang S, Wa Q, Pan J, Peng X, Ren D, Huang
Y, Chen X and Tang Y: Downregulation of miR-141-3p promotes bone
metastasis via activating NF-κB signaling in prostate cancer. J Exp
Clin Cancer Res. 36(173)2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zhou Y, Zhong JH, Gong FS and Xiao J:
MiR-141-3p suppresses gastric cancer induced transition of normal
fibroblast and BMSC to cancer-associated fibroblasts via targeting
STAT4. Exp Mol Pathol. 107:85–94. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li W, Cui Y, Wang D, Wang Y and Wang L:
MiR-141-3p functions as a tumor suppressor through directly
targeting ZFR in non-small cell lung cancer. Biochem Biophys Res
Commun. 509:647–656. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liu CZ, Ye ZH, Ma J, He RQ, Liang HW, Peng
ZG and Chen G: A qRT-PCR and gene functional enrichment study
focused on downregulation of miR-141-3p in hepatocellular carcinoma
and its clinicopathological significance. Technol Cancer Res Treat.
16:835–849. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Fang M, Huang W, Wu X, Gao Y, Ou J, Zhang
X and Li Y: MiR-141-3p suppresses tumor growth and metastasis in
papillary thyroid cancer via targeting Yin Yang 1. Anat Rec
(Hoboken). 302:258–268. 2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yin J, Bai Z, Zhang J, Zheng Z, Yao H, Ye
P, Li J, Gao X and Zhang Z: Burden of colorectal cancer in China,
1990-2017: Findings from the Global Burden of Disease Study 2017.
Chin J Cancer Res. 31:489–498. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Han D, Wang M, Ma N, Xu Y, Jiang Y and Gao
X: Long noncoding RNAs: Novel players in colorectal cancer. Cancer
Lett. 361:13–21. 2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Shi SJ, Wang LJ, Yu B, Li YH, Jin Y and
Bai XZ: LncRNA-ATB promotes trastuzumab resistance and
invasion-metastasis cascade in breast cancer. Oncotarget.
6:11652–11663. 2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wang P, Ning S, Zhang Y, Li R, Ye J, Zhao
Z, Zhi H, Wang T, Guo Z and Li X: Identification of
lncRNA-associated competing triplets reveals global patterns and
prognostic markers for cancer. Nucleic Acids Res. 43:3478–3489.
2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Guzel E, Okyay TM, Yalcinkaya B,
Karacaoglu S, Gocmen M and Akcakuyu MH: Tumor suppressor and
oncogenic role of long non-coding RNAs in cancer. North Clin
Istanb. 7:81–86. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Liao Q, He W, Liu J, Cen Y, Luo L, Yu C,
Li Y, Chen S and Duan S: Identification and functional annotation
of lncRNA genes with hypermethylation in colorectal cancer. Gene.
572:259–265. 2015.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Shi J, Li X, Zhang F, Zhang C, Guan Q, Cao
X, Zhu W, Zhang X, Cheng Y, Ou K, et al: Circulating lncRNAs
associated with occurrence of colorectal cancer progression. Am J
Cancer Res. 5:2258–2265. 2015.PubMed/NCBI
|
|
44
|
Yang XS, Wang GX and Luo L: Long
non-coding RNA SNHG16 promotes cell growth and metastasis in
ovarian cancer. Eur Rev Med Pharmacol Sci. 22:616–622.
2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Cai C, Huo Q, Wang X, Chen B and Yang Q:
SNHG16 contributes to breast cancer cell migration by competitively
binding miR-98 with E2F5. Biochem Biophys Res Commun. 485:272–278.
2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Sun J and Zhang Y: LncRNA XIST enhanced
TGF-β2 expression by targeting miR-141-3p to promote pancreatic
cancer cells invasion. Biosci Rep. 39(BSR20190332)2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Liang Z, Li X, Liu S, Li C, Wang X and
Xing J: MiR-141-3p inhibits cell proliferation, migration and
invasion by targeting TRAF5 in colorectal cancer. Biochem Biophys
Res Commun. 514:699–705. 2019.PubMed/NCBI View Article : Google Scholar
|
